Real-time 4-D radiotherapy for lung cancer

Cancer Science

Volumn 103, Issue 1, 2012, Pages 1-6

  Shirato, Hiroki ^a   Onimaru, Rikiya ^a   Ishikawa, Masayori ^b   Kaneko, Jun Ichi ^a   Takeshima, Tsuguhide ^a   Mochizuki, Kenta ^a   Shimizu, Shinichi ^a   Umegaki, Kikuo ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

^b HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER RADIOTHERAPY; FLUOROSCOPY; FOUR DIMENSIONAL COMPUTED TOMOGRAPHY; GAMMA RADIATION; HUMAN; LUNG CANCER; PRIORITY JOURNAL; PROTON THERAPY; REVIEW; STEREOTACTIC BODY RADIATION THERAPY;

ANIMALS; FOUR-DIMENSIONAL COMPUTED TOMOGRAPHY; HUMANS; LUNG NEOPLASMS;

EID: 84855485474     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2011.02114.x     Document Type: Review

References (76)

1. Das IJ, Cheng CW, Chopra KL, Mitra RK, Srivastava SP, Glatstein E. Intensity-modulated radiation therapy dose prescription, recording, and delivery: patterns of variability among institutions and treatment planning systems. J Natl Cancer Inst 2008; 100: 300-7.
2. Verellen D, De Ridder M, Linthout N, Tournel K, Soete G, Storme G. Innovations in image-guided radiotherapy. Nat Rev Cancer 2007; 7: 949-60.
3. Fowler JF, Tomé WA, Fenwick JD, Mehta MP. A challenge to traditional radiation oncology. Int J Radiat Oncol Biol Phys 2004; 60: 1241-56.
4. Shirato H, Shimizu S, Shimizu T, Nishioka T, Miyasaka K. Real-time tumour-tracking radiotherapy. Lancet 1999; 353: 1331-2.
5. Uematsu M, Shioda A, Suda A et al. Computed tomography-guided frameless stereotactic radiotherapy for stage I non-small cell lung cancer: a 5-year experience. Int J Radiat Oncol Biol Phys 2001; 51: 666-70.
6. Onishi H, Shirato H, Nagata Y et al. Stereotactic body radiotherapy (SBRT) for operable stage i non-small-cell lung cancer: can SBRT Be comparable to surgery? Int J Radiat Oncol Biol Phys 2010; doi: [Epub ahead of print].
7. Timmerman R, Paulus R, Galvin J et al. Stereotactic body radiation therapy for inoperable early stage lung cancer. JAMA 2010; 303: 1070-6.
8. Bengua G, Ishikawa M, Sutherland K et al. Evaluation of the effectiveness of the stereotactic body frame in reducing respiratory intrafractional organ motion using the real-time tumor-tracking radiotherapy system. Int J Radiat Oncol Biol Phys 2010; 77: 630-6.
9. Starkschall G, Balter P, Britton K, McAleer MF, Cox JD, Mohan R. Interfractional reproducibility of lung tumor location using various methods of respiratory motion mitigation. Int J Radiat Oncol Biol Phys 2011; 79: 596-601.
10. Nagata Y, Hiraoka M, Mizowaki T et al. Survey of stereotactic body radiation therapy in Japan by the Japan 3-D Conformal External Beam Radiotherapy Group. Int J Radiat Oncol Biol Phys 2009; 75: 343-7.
11. Timmerman R, McGarry R, Yiannoutsos C et al. Excessive toxicity when treating central tumors in a phase II study of stereotactic body radiation therapy for medically inoperable early-stage lung cancer. J Clin Oncol 2006; 24: 4833-9.
12. Borst GR, Ishikawa M, Nijkamp J et al. Radiation pneumonitis in patients treated for malignant pulmonary lesions with hypofractionated radiation therapy. Radiother Oncol 2009; 91: 307-13.
13. Yuan X, Liao Z, Liu Z et al. Single nucleotide polymorphism at rs1982073:T869C of the TGFbeta 1 gene is associated with the risk of radiation pneumonitis in patients with non-small-cell lung cancer treated with definitive radiotherapy. J Clin Oncol 2009; 27: 3370-8.
14. Shimizu S, Shirato H, Kagei K et al. Impact of respiratory movement on the computed tomographic images of small lung tumors in three-dimensional (3D) radiotherapy. Int J Radiat Oncol Biol Phys 2000; 46: 1127-33.
15. Shirato H, Shimizu S, Kitamura K et al. Four-dimensional treatment planning and fluoroscopic real-time tumor tracking radiotherapy for moving tumor. Int J Radiat Oncol Biol Phys 2000; 48: 435-42.
16. Seppenwoolde Y, Shirato H, Kitamura K et al. Precise and real-time measurement of 3D tumor motion in lung due to breathing and heartbeat, measured during radiotherapy. Int J Radiat Oncol Biol Phys 2002; 53: 822-34.
17. Shirato H, Seppenwoolde Y, Kitamura K, Onimura R, Shimizu S. Intrafractional tumor motion: lung and liver. Semin Radiat Oncol 2004; 14: 10-8.
18. Kamino Y, Takayama K, Kokubo M et al. Development of a four-dimensional image-guided radiotherapy system with a gimbaled X-ray head. Int J Radiat Oncol Biol Phys 2006; 66: 271-8.
19. Miyamoto N, Ishikawa M, Bengua G et al. Optimization of fluoroscopy parameters using pattern matching prediction in the real-time tumor-tracking radiotherapy system. Phys Med Biol 2011; 56: 4803-13.
20. Siddique S, Fiume E, Jaffray DA. Minimizing dose during fluoroscopic tracking through geometric performance feedback. Med Phys 2011; 38: 2494-507.
21. Onimaru R, Shirato H, Fujino M et al. The effect of tumor location and respiratory function on tumor movement estimated by real-time tracking radiotherapy (RTRT) system. Int J Radiat Oncol Biol Phys 2005; 63: 164-9.
22. Onodera Y, Nishioka N, Yasuda K et al. Relationship between diseased lung tissues on computed tomography and motion of fiducial marker near lung cancer. Int J Radiat Oncol Biol Phys 2011; 79: 1408-13.
23. Shirato H, Suzuki K, Sharp GC et al. Speed and amplitude of lung tumor motion precisely detected in four-dimensional setup and in real-time tumor-tracking radiotherapy. Int J Radiat Oncol Biol Phys 2006; 64: 1229-36.
24. Coolens C, Webb S, Shirato H, Nishioka K, Evans PM. A margin model to account for respiration-induced tumor motion and its variability. Phys Med Biol 2008; 53: 4317-30.
25. Seppenwoolde Y, Berbeco RI, Nishioka S, Shirato H, Heijmen B. Accuracy of tumor motion compensation algorithm from a robotic respiratory tracking system: a simulation study. Med Phys 2007; 34: 2774-84.
26. Ionascu D, Jiang SB, Nishioka S, Shirato H, Berbeco RI. Internal-external correlation investigations of respiratory induced motion of lung tumors. Med Phys 2007; 34: 3893-903.
27. Hoisak JD, Sixel KE, Tirona R, Cheung PC, Pignol JP. Correlation of lung tumor motion with external surrogate indicators of respiration. Int J Radiat Oncol Biol Phys 2004; 60: 1298-306.
28. Hunjan S, Starkschall G, Prado K, Dong L, Balter P. Lack of correlation between external fiducial positions and internal tumor positions during breath-hold CT. Int J Radiat Oncol Biol Phys 2010; 76: 1586-91.
29. Berbeco RI, Nishioka S, Shirato H, Chen GT, Jiang SB. Residual motion of lung tumours in gated radiotherapy with external respiratory surrogates. Phys Med Biol 2005; 50: 3655-67.
30. Zhao B, Yang Y, Li T, Li X, Heron DE, Huq MS. Statistical analysis of target motion in gated lung stereotactic body radiation therapy. Phys Med Biol 2011; 56: 1385-95.
31. Malinowski K, McAvoy TJ, George R, Dietrich S, D'Souza WD. Incidence of changes in respiration-induced tumor motion and its relationship with respiratory surrogates during individual treatment fractions. Int J Radiat Oncol Biol Phys 2011; doi: [Epub ahead of print].
32. Vedam SS, Keall PJ, Kini VR, Mostafavi H, Shukla HP, Mohan R. Acquiring a four-dimensional computed tomography dataset using an external respiratory signal. Phys Med Biol 2003; 48: 45-62.
33. Keall PJ, Mageras GS, Balter JM et al. The management of respiratory motion in radiation oncology report of AAPM Task Group 76. Med Phys 2006; 33: 3874-900.
34. George R, Chung TD, Vedam SS et al. Audio-visual biofeedback for respiratory-gated radiotherapy: impact of audio instruction and audio-visual biofeedback on respiratory-gated radiotherapy. Int J Radiat Oncol Biol Phys 2006; 65: 924-33.
35. Jiang SB, Wolfgang J, Mageras GS. Quality assurance challenges for motion-adaptive radiation therapy: gating, breath holding, and four-dimensional computed tomography. Int J Radiat Oncol Biol Phys 2008; 71(1 Suppl): S103-7.
36. Cui G, Gopalan S, Yamamoto T, Berger J, Maxim PG, Keall PJ. Commissioning and quality assurance for a respiratory training system based on audiovisual biofeedback. J Appl Clin Med Phys 2010; 11: 3262.
37. Neicu T, Berbeco R, Wolfgang J, Jiang SB. Synchronized moving aperture radiation therapy (SMART): improvement of breathing pattern reproducibility using respiratory coaching. Phys Med Biol 2006; 51: 617-36.
38. Onishi H, Kawakami H, Marino K et al. A simple respiratory indicator for irradiation during voluntary breath holding: a one-touch device without electronic materials. Radiology 2010; 255: 917-23.
39. Haasbeek CJ, Spoelstra FO, Lagerwaard FJ et al. Impact of audio-coaching on the position of lung tumors. Int J Radiat Oncol Biol Phys 2008; 71: 1118-23.
40. Shirato H, Shimizu S, Kitamura K, Onimaru R. Organ motion in image-guided radiotherapy: lessons from real-time tumor-tracking radiotherapy. Int J Clin Oncol 2007; 12: 8-16.
41. Fledelius W, Keall PJ, Cho B et al. Tracking latency in image-based dynamic MLC tracking with direct image access. Acta Oncol 2011; 50: 952-9.
42. Wu H, Sharp GC, Salzberg B, Kaeli D, Shirato H, Jiang SB. A finite state model for respiratory motion analysis in image guided radiation therapy. Phys Med Biol 2004; 49: 5357-72.
43. Vedam SS, Keall PJ, Docef A, Todor DA, Kini VR, Mohan R. Predicting respiratory motion for four-dimensional radiotherapy. Med Phys 2004; 31: 2274-83.
44. Sharp GC, Jiang SB, Shimizu S, Shirato H. Prediction of respiratory tumour motion for real-time image-guided radiotherapy. Phys Med Biol 2004; 49: 425-40.
45. Murphy MJ, Pokhrel D. Optimization of an adaptive neural network to predict breathing. Med Phys 2009; 36: 40-7.
46. Ruan D, Fessler JA, Balter JM. Real-time prediction of respiratory motion based on local regression methods. Phys Med Biol 2007; 52: 7137-52.
47. Ren Q, Nishioka S, Shirato H, Berbeco RI. Adaptive prediction of respiratory motion for motion compensation radiotherapy. Phys Med Biol 2007; 52: 6651-61.
48. Roland T, Mavroidis P, Shi C, Papanikolaou N. Incorporating system latency associated with real-time target tracking radiotherapy in the dose prediction step. Phys Med Biol 2010; 55: 2651-68.
49. Onimaru R, Fujino M, Yamazaki K et al. Steep dose-response relationship for stage I non-small-cell lung cancer using hypofractionated high-dose irradiation by real-time tumor-tracking radiotherapy. Int J Radiat Oncol Biol Phys 2008; 70: 374-81.
50. Taguchi H, Sakuhara Y, Hige S et al. Intercepting radiotherapy using a real-time tumor-tracking radiotherapy system for highly selected patients with hepatocellular carcinoma unresectable with other modalities. Int J Radiat Oncol Biol Phys 2007; 69: 376-80.
51. Sakakibara-Konishi J, Oizumi S, Kinoshita I et al. Phase I study of concurrent real-time tumor-tracking thoracic radiation therapy with paclitaxel and carboplatin in locally advanced non-small cell lung cancer. Lung Cancer 2011; 74: 248-52.
52. Dieterich S, Gibbs IC. The CyberKnife in clinical use: current roles, future expectations. Front Radiat Ther Oncol 2011; 43: 181-94.
53. Grills IS, Yan D, Black QC, Wong CY, Martinez AA, Kestin LL. Clinical implications of defining the gross tumor volume with combination of CT and 18FDG-positron emission tomography in non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 2007; 67: 709-19.
54. Kaneko J, Fujita F, Shirato H, Takada E. Dynamic tumor radiation treatment apparatus and dynamic tumor radiation treatment program. PCT/JP2008/052944, US 2010/0142677 A1.
55. Xu T, Wong JT, Shikhaliev PM, Ducote JL, Al-Ghazi MS, Molloi S. Real-time tumor tracking using implanted positron emission markers: concept and simulation study. Med Phys 2006; 33: 2598-609.
56. Chamberland M, Wassenaar R, Spencer B, Xu T. Performance evaluation of real-time motion tracking using positron emission fiducial markers. Med Phys 2011; 38: 810-9.
57. Yamaguchi S, Ishikawa M, Bengua G et al. A feasibility study of a molecular-based patient setup verification method using a parallel-plane PET system. Phys Med Biol 2011; 56: 965-77.
58. Bentzen SM, Gregoire V. Molecular imaging-based dose painting: a novel paradigm for radiation therapy prescription. Semin Radiat Oncol 2011; 21: 101-10.
59. Lin Z, Mechalakos J, Nehmeh S et al. The influence of changes in tumor hypoxia on dose-painting treatment plans based on 18F-FMISO positron emission tomography. Int J Radiat Oncol Biol Phys 2008; 70: 1219-28.
60. Durante M, Loeffler JS. Charged particles in radiation oncology. Nat Rev Clin Oncol 2010; 7: 37-43.
61. Kooy HM, Clasie BM, Lu HM et al. A case study in proton pencil-beam scanning delivery. Int J Radiat Oncol Biol Phys 2010; 76: 624-30.
62. Sugahara S, Oshiro Y, Nakayama H et al. Proton beam therapy for large hepatocellular carcinoma. Int J Radiat Oncol Biol Phys 2010; 76: 460-6.
63. Kooy H, Loeffler JS, DeLaney TF. Proton beam therapy. Br J Cancer 2005; 93: 849-54.
64. Kadoya N, Obata Y, Kato T et al. Dose-volume comparison of proton radiotherapy and stereotactic body radiotherapy for non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 2011; 79: 1225-31.
65. Macdonald OK, Kruse JJ, Miller JM et al. Proton beam radiotherapy versus three-dimensional conformal stereotactic body radiotherapy in primary peripheral, early-stage non-small-cell lung carcinoma: a comparative dosimetric analysis. Int J Radiat Oncol Biol Phys 2009; 75: 950-8.
66. Loeffler JS. Technology assessment in radiation oncology: time for reassessment? Nat Clin Pract Oncol 2008; 5: 299.
67. Suit H, Kooy H, Trofimov A et al. Should positive phase III clinical trial data be required before proton beam therapy is more widely adopted? No. Radiother Oncol 2008; 86: 148-53.
68. Brada M, Pijls-Johannesma M, De Ruysscher D. Current clinical evidence for proton therapy. Cancer J 2009; 15: 319-24.
69. Hall EJ. Intensity-modulated radiation therapy, protons, and the risk of second cancers. Int J Radiat Oncol Biol Phys 2006; 65: 1-7.
70. Smith A, Gillin M, Bues M et al. The M. D. Anderson proton therapy system. Med Phys 2009; 36: 4068-83.
71. Gillin MT, Sahoo N, Bues M et al. Commissioning of the discrete spot scanning proton beam delivery system at the University of Texas M.D. Anderson Cancer Center, Proton Therapy Center, Houston. Med Phys 2010; 37: 154-63.
72. af Rosenschöld PM, Aznar MC, Nygaard DE et al. A treatment planning study of the potential of geometrical tracking for intensity modulated proton therapy of lung cancer. Acta Oncol 2010; 49: 1141-8.
73. Petersen JB, Lassen Y, Hansen AT, Muren LP, Grau C, Høyer M. Normal liver tissue sparing by intensity-modulated proton stereotactic body radiotherapy for solitary liver tumours. Acta Oncol 2011; 50: 823-8.
74. Imai R, Kamada T, Tsuji H et al. Effect of carbon ion radiotherapy for sacral chordoma: results of phase i-ii and phase ii clinical trials. Int J Radiat Oncol Biol Phys 2010; 77: 1470-6.
75. Furukawa T, Inaniwa T, Sato S et al. Performance of the NIRS fast scanning system for heavy-ion radiotherapy. Med Phys 2010; 37: 5672-82.
76. Newhauser WD, Durante M. Assessing the risk of second malignancies after modern radiotherapy. Nat Rev Cancer 2011; 11: 438-48.